Doxorubicin Hydrochloride Liposomal Injection 20 mg/50 mg – Benefits, Dose, Side Effects & FAQs
Description
Doxorubicin Hydrochloride Liposomal Injection 20 mg/50 mg is a prescription oncology medicine containing liposomal doxorubicin. It is administered by intravenous infusion under the supervision of qualified healthcare professionals and is used for specific cancer indications.
Doxorubicin Liposomal Injection Uses
Doxorubicin Hydrochloride Liposomal Injection may be used for:
Ovarian cancer that has progressed after platinum-based chemotherapy.
AIDS-related Kaposi's sarcoma in appropriate patients.
Multiple myeloma, in combination with bortezomib, for eligible patients.
Treatment selection depends on the patient's diagnosis, previous therapy and overall medical condition.
Benefits of Doxorubicin Liposomal Injection
Provides an established anthracycline chemotherapy option.
Liposomal formulation delivers doxorubicin in a specialized formulation.
Available in 20 mg and 50 mg vial strengths.
Can be used in specific oncology treatment protocols.
May be administered alone or with other anticancer medicines depending on the indication.
Important: Benefits vary between patients and should be assessed by an oncologist.
Doxorubicin Liposomal Injection 20 mg/50 mg Dose
The dose is determined by the treating oncologist and is generally based on the indication and body-surface area.
Typical labeled doses include:
Indication Recommended Dose
Ovarian cancer 50 mg/m² IV every 28 days
AIDS-related Kaposi's sarcoma 20 mg/m² IV every 21 days
Multiple myeloma 30 mg/m² IV on Day 4 of a 21-day cycle, following bortezomib
The injection must be administered by a healthcare professional. It should not be self-administered or given as an IV bolus.
Dose modification or treatment interruption may be required depending on blood counts, adverse reactions and other patient-specific factors.
Common Side Effects
Possible side effects include:
Fatigue and weakness
Nausea and vomiting
Loss of appetite
Fever
Diarrhea or constipation
Mouth sores
Skin rash
Hand-foot syndrome
Anemia
Neutropenia
Thrombocytopenia
Serious Side Effects
Important serious risks include cardiomyopathy/heart dysfunction, severe infusion-related reactions, serious hypersensitivity reactions and significant bone-marrow suppression.
Patients should immediately inform their healthcare provider about severe breathing difficulty, chest symptoms, severe allergic reactions, high fever or other serious symptoms.
Doxorubicin Liposomal Injection in USA, UK, UAE & South Africa
Doxorubicin Hydrochloride Liposomal Injection is a prescription oncology medicine. Availability, registration, importation and dispensing requirements can differ between the USA, UK, UAE and South Africa.
Hospitals, oncology centers, licensed pharmacies and authorized pharmaceutical distributors should follow applicable local regulations. Patients should obtain and use the medicine only under medical supervision.
Storage & Handling
This is a cytotoxic chemotherapy medicine and must be handled, prepared and disposed of according to the manufacturer's instructions and applicable healthcare safety requirements. Storage conditions should always be checked against the specific product's approved labeling.
Frequently Asked Questions
1. What is Doxorubicin Hydrochloride Liposomal Injection?
It is a liposomal formulation of doxorubicin, an anthracycline chemotherapy medicine used for specific cancer indications.
2. What strengths are available?
Common vial strengths include 20 mg and 50 mg. The exact presentation may vary by manufacturer and market.
3. What cancers can Doxorubicin Liposomal Injection treat?
It is used for selected cases of ovarian cancer, AIDS-related Kaposi's sarcoma and multiple myeloma in combination with bortezomib.
4. How is it administered?
It is administered by intravenous infusion by trained healthcare professionals.
5. Is 20 mg or 50 mg the patient's dose?
Not necessarily. 20 mg and 50 mg refer to vial strengths. The prescribed dose is calculated by the oncologist according to the indication and patient-specific factors.
6. Can Doxorubicin Liposomal Injection affect the heart?
Yes. Doxorubicin can cause cardiotoxicity and cardiomyopathy. Appropriate cardiac evaluation and monitoring may be required.
7. Can it be purchased without a prescription?
No. It is a prescription chemotherapy medicine and should only be supplied and administered through appropriate medical channels.
8. Is Doxorubicin Liposomal Injection the same as conventional doxorubicin?
No. Both contain doxorubicin, but the liposomal formulation has a different pharmaceutical delivery system and dosing recommendations.
Medical Disclaimer
This content is provided for general educational and SEO purposes and does not replace medical advice. Doxorubicin Hydrochloride Liposomal Injection is a potent prescription chemotherapy medicine. Treatment, dosage and monitoring must be determined by a qualified oncology professional according to the applicable approved product information.
